Latent Earns a 94.5 in the 2026 KLAS Emerging Company Spotlight

KLAS scored Latent Health 94.5 overall, with A+ ratings for likelihood to recommend, partnership, and would buy again, in the first KLAS Spotlight report on enterprise pharmacy intelligence.

Latent Raises $80M to Close the Gap Between Diagnosis and Treatment